Data will detail how the Terumo BCT’s Quantum Flex® Cell Expansion System and Finia® Fill and Finish System with BioCentriq’s LEAP™ Advanced Therapy Platform can help accelerate delivery of CAR-T therapies to patients LAKEWOOD, Colo., …
Read more
NEWARK, NJ, October 3, 2023 – BioCentriq, a cell therapy CDMO (contract development and manufacturing organization), announced today the appointment of Jennifer Manning, MPA, as its Chief Commercial Officer, effective October 3, 2023. “We are …
Read more
This month, BioCentriq hosted a webinar called The Role of Platform Processes in Cell Therapy. It explored the challenges associated with cell therapy manufacturing, including high cost and complexity, and offered an alternate pathway for …
Read more
Upcoming Webinar: The Role of Platform Processes in Cell Therapy Manufacturing and Development Date & Time: September 13, 2023 | 02:00 PM EDT | Register Now! Cell therapies can revolutionize treatment possibilities, offering potential cures …
Read more
Discover how you can reduce timelines and costs, de-risk clinical trials and get to patients faster with BioCentriq’s LEAPTM platform for advanced therapies. Discover BioCentriq’s Capabilities Our team is ready to meet with you and …
Read more
BioCentriq is happy to announce that we’ve been selected to present our capabilities at this year’s Meeting on the Mesa. The conference is from October 10-12 and is in Carlsbad, California. Organized by the Alliance …
Read more
Dedicated to bringing you top experts in the field, Biotech Banter promises a host of thought leaders and experienced professionals that can provide you with insight you might otherwise miss. The first episode features Dr. …
Read more
In the fast-paced, funding-constrained world of drug therapy development, finding the right balance between speed, quality, and cost is crucial. Investing time and money in thorough research and development (R&D) is imperative for successful clinical manufacturing; …
Read more
Newark, New Jersey – June 27, 2023 – BioCentriq and Cytiva announced today that they have received funding from NIIMBL to develop a viral and exotoxin clearance platform for adeno-associated virus (AAV) manufacturing. The goal of …
Read more
If you attended this year’s jam-packed ISCT annual event in Paris, there’s a good chance you came across one of our five team members during the four-day meeting. As a CDMO specializing in cell therapy …
Read more
Authored by Amy Lamperti BioCentriq’s Vice President of Marketing On May 23rd BioCentriq had the great pleasure of hosting ten leaders from five different Salvadoran businesses who are participants in Bpeace’s Pharma Maximizer program including …
Read more
NEWARK, NJ, June 6, 2023 – BioCentriq®, a strategic CDMO (contract development and manufacturing organization) specializing in cell therapy announced today that it has expanded its partnership with Kytopen, a Cambridge based startup spun out …
Read more